Citadel Advisors’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-45,708
| Closed | -$111K | – | 10335 |
|
|
2019
Q1 | $111K | Buy |
+45,708
| New | +$98.3K | ﹤0.01% | 8511 |
|
|
2018
Q4 | – | Sell |
-10,453
| Closed | -$24K | – | 10166 |
|
|
2018
Q3 | $24K | Buy |
+10,453
| New | +$22.3K | ﹤0.01% | 8986 |
|
|
2018
Q1 | – | Sell |
-32,680
| Closed | -$25K | – | 9095 |
|
|
2017
Q4 | $25K | Buy |
+32,680
| New | +$23.9K | ﹤0.01% | 7799 |
|
|
2017
Q3 | – | Sell |
-17,859
| Closed | -$21K | – | 8362 |
|
|
2017
Q2 | $21K | Buy |
+17,859
| New | +$20.4K | ﹤0.01% | 7280 |
|
|
2017
Q1 | – | Sell |
-18,595
| Closed | -$30K | – | 8344 |
|
|
2016
Q4 | $30K | Buy |
+18,595
| New | +$31.2K | ﹤0.01% | 6993 |
|
|
2016
Q3 | – | Sell |
-10,236
| Closed | -$19K | – | 8071 |
|
|
2016
Q2 | $19K | Buy |
+10,236
| New | +$19.2K | ﹤0.01% | 6637 |
|
|
2014
Q1 | – | Sell |
-11,743
| Closed | -$20K | – | 8116 |
|
|
2013
Q4 | $20K | Buy |
+11,743
| New | +$18.3K | ﹤0.01% | 6465 |
|
|
2013
Q3 | – | Sell |
-13,522
| Closed | -$22K | – | 6962 |
|
|
2013
Q2 | $22K | Buy |
+13,522
| New | +$25K | ﹤0.01% | 6037 |
|
Citadel Advisors's CASM Position: Q2 2019 in Review
Citadel Advisors sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 45,708 shares — an estimated $111K sold.
Citadel Advisors first reported a position in CASM in Q2 2013 and held it in 8 quarters. The position peaked at $111K in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Citadel Advisors reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- Citadel Advisors sold 45,708 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $111K.
- Citadel Advisors first reported a position in CAS Medical Systems, Inc. in Q2 2013 and held it in 8 quarters.
- Citadel Advisors's CAS Medical Systems, Inc. position peaked at $111K in Q1 2019.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.